Trial Profile
Efficacy of sofosbuvir and ribavirin in hepatitis C virus (HCV) infected patients with genotype 2 and 3: Multicentre analysis of 3 academic medical centres in US
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Aug 2015
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 13 Aug 2015 New trial record